Delivery Order SPE2DB24D1007-SPE2DB24FBZKU
Award Date
5/15/24
Potential Completion Date
5/16/24
Potential Value
$6.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Methotrexate 2.5 mg tablets. The contract, valued at $2,294.28, is a firm-fixed-price delivery order with a completion date of July 18, 2024. While there is no set-aside designation, AmerisourceBergen has been awarded numerous federal contracts by the DLA and other agencies, including a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $1,563.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the delivery of 4,565,634,382 units of Methotrexate 2.5 mg tablets. The contract has a completion date of August 30, 2024 and is a Firm Fixed Price Delivery Order. This contract is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,076.18 firm fixed-price delivery order is for the supply of 4,566,438,147 units of Methotrexate 2.5 mg tablets, a common medication used to treat various medical conditions. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
The federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,565,843,623 units of Methotrexate 2.5 mg tablets. The $3,853.16 firm fixed-price award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract has an ultimate completion date of September 18, 2024 and does not use a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Methotrexate 2.5 mg tablets. The contract has a ceiling value of $9,777.14 and an ultimate completion date of May 1, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc., the parent company of AmerisourceBergen Drug Corp. This IDC, valued at up to...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,567,678,591 units of Methotrexate 2.5 mg tablets in 100-count bottles. The contract has a ceiling value of $21,076.61 and runs through March 25, 2025. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite...
This federal contract award, valued at $3,971.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,143,768 units of methotrexate 2.5 mg tablets, a medication used to treat various medical conditions. The contract is a firm-fixed-price delivery order with a performance period extending through May 6, 2025. Amerisourcebergen Drug Corp is also the holder of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,200.86 firm fixed price delivery order is for the supply of 4,566,189,069 tablets of Methotrexate 2.5 mg, with an ultimate completion date of October 24, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Methotrexate 2.5 mg tablets. The delivery order has a ceiling value of $1,906.78 and an ultimate completion date of September 11, 2024. The contract is a firm-fixed price type. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract to provide the specified medication to support the healthcare needs of military treatment facilities and other...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of METHOTREXATE 2.5 MG TABLET 100S. The contract has a ceiling value of $8,542.21 and is a Firm Fixed Price Delivery Order with a performance period ending on May 29, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...